Carregant...

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis

OBJECTIVE: To evaluate the comparative efficacy and safety of Janus kinase (JAK) inhibitors and biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to at least one disease-modifying antirheumatic drug (DMARD). METHODS: PubM...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Musculoskelet Dis
Autors principals: Weng, Chenghua, Xue, Leixi, Wang, Qing, Lu, Wentian, Xu, Jiajun, Liu, Zhichun
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989112/
https://ncbi.nlm.nih.gov/pubmed/33815570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X21999564
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!